15:59 Dec 05

Caplin Point Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1963.40
-12.70 (-0.64%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Caplin Point Laboratories Ltd. Financials

Caplin Point Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1963.40
-12.70 (-0.64%)
15:59 Dec 05
Quality
image/svg+xml

71/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

42/100
Technically Neutral

Strength

9

Weakness

3

Opportunity

1

Threats

1

19.32 %

ROE %

16.71 %

ROA %

77.46

EPS

365.25

BVPS

27.68 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1269.41 1466.73 1694.1 1937.47 1988.73
Operating Expenses +
874.74 1025.67 1142.66 1290.54 1315.86
Raw Material
589.43 710.15 798.73 732.28 777.41
Increase Decrease in Cost
-31.92 -46.94 -74.55 38.56 3.2
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
115.3 136.99 143.59 177.72 180.73
Miscellaneous Expenses
996.17 1233.21 1392.73 1309.64 354.52
Operating Profit
394.67 441.06 551.44 646.93 672.87
Other Income
38.75 55.98 66.94 96.43 101.01
Depreciation
46.9 44.99 53.44 65.96 66.29
Interest
0.7 0.78 0.78 0.61 0.74
Profit before tax and exceptio..
385.82 451.27 564.16 676.79 706.85
Exceptional Items
0 0.08 0.27 -0.01 0
PBT
385.82 451.35 564.43 676.78 706.85
Provision for Taxation
77.37 74.36 103.01 135.69 139.93
Net Profit
308.45 376.99 461.42 541.09 566.92
NET Profit after MI
299.84 376.26 457.09 536.31 565.13
EPS
39.61 49.18 60.19 70.25 74.35
Operating Profit Margin (%)
31.09 30.07 32.55 33.39 33.83
Net Profit Margin (%)
23.62 25.65 26.98 27.68 28.42

Caplin Point Laboratories Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 70.60 70.60 70.60 70.60 70.60 70.60
FII 6.50 6.20 5.70 4.90 3.70 3.40
Public 2.10 2.20 2.00 2.10 1.90 1.50
Others 20.80 21.00 21.70 22.40 23.80 24.50
Shareholder Shares Holding %
Download Our App On: